GRASSO MARC 4
4 · Kyverna Therapeutics, Inc. · Filed Jul 1, 2025
Insider Transaction Report
Form 4
GRASSO MARC
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-06-30−450,000→ 450,000 totalExercise: $3.07Exp: 2035-06-30→ Common Stock (450,000 underlying)
Footnotes (1)
- [F1]1/4th of the shares subject to the option shall vest on June 30, 2026, and 1/48th of the shares subject to the option shall vest following each one-month period thereafter, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.